KUALA LUMPUR, May 3 — Leading Asia-Pacific pharmacist experts together with P&G Health have launched the region’s first community pharmacist guideline.
To improve the identification, assessment and management of peripheral neuropathy (PN) in daily practice.
The “Empowering Community Pharmacists” consensus introduces practical screening tools, risk identification methods and structured.
Care pathways to address underdiagnosis and delayed treatment across the region, where up to 80% of cases remain undetected.
Experts said pharmacists are uniquely positioned as first-contact healthcare providers to improve early detection, counselling and referral, supported by new tools and training platforms such as P&G Nerve Connect.
